GCP
CBIO

GSA Capital Partners’s Crescent Biopharma CBIO Stock Holding History

GSA Capital Partners’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-837
Closed -$14K – 1753
2024
Q3 		$14K Buy
+837
New +$17.6K ﹤0.01% 1535
2024
Q2 		– Sell
-183
Closed -$55K – 1782
2024
Q1 		$55K Sell
183
-1,827
-91% -$546K ﹤0.01% 1529
2023
Q4 		$474K Buy
2,010
+1,072
+114% +$167K 0.04% 830
2023
Q3 		$141K Buy
+938
New +$148K 0.01% 1352
2022
Q1 		– Sell
-1,461
Closed -$210K – 1555
2021
Q4 		$210K Buy
+1,461
New +$265K 0.03% 1185
2020
Q2 		– Sell
-238
Closed -$54K – 798
2020
Q1 		$54K Buy
238
+84
+55% +$32.1K 0.01% 956
2019
Q4 		$82K Buy
+154
New +$83.4K 0.01% 1352
2019
Q3 		– Sell
-155
Closed -$185K – 1503
2019
Q2 		$185K Buy
+155
New +$185K 0.02% 1260
2019
Q1 		– Sell
-215
Closed -$204K – 1532
2018
Q4 		$204K Buy
+215
New +$259K 0.02% 1096
2018
Q1 		– Sell
-867
Closed -$1.46M – 1682
2017
Q4 		$1.46M Buy
+867
New +$1.15M 0.09% 374

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return